IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-02-07 (ajmc.com)
Gains in Capability, Losses in Access to Primary Care After COVID-19
Better access and capability scores were associated with integrated practice ownership and participation in accountable care organizations.
Read more
2025-01-15 (actu.fr)
Flu epidemic in Brittany: is the situation worse than in other regions?
The seasonal flu epidemic is growing in Brittany. Hospital emergency rooms and SOS Médecins have a lot of patients. What is the situation at the start of 2025?
Read more
2024-11-08 (farmacja.pl)
Pandemic, war and inflation. How did they affect drug prices in Poland?
IQVIA is a leading global provider of clinical trials, commercial analytics and health information. The company's experts analyzed how recently […]
Read more
2024-10-23 (theglobeandmail.com)
Vaccines bring $2.5-billion in value to Canadian economy, health care system, study says
Analysis estimates savings to the health care system and employers from adults taking six different vaccines recommended by the National Advisory Committee on Immunization
Read more
2024-07-30 (pressdigital.es)
The sale of Covid tests soars in Spanish pharmacies
In June, sales of antigen tests reached 4 million euros, 198% more than the previous month and 162% compared to the same month last year.
Read more
2024-07-10 (meridionews.it)
Online pharmacies, 2024 starts on a positive note: turnover and packages sold are growing
Ten years have passed since online pharmacies and parapharmacies were made legal in our country. Despite the time that has passed since then and the almost five years that have passed since the beginning of the Covid emergency, a watershed that has given an unparalleled boost to e-commerce turnover
Read more
2024-06-13 (pharmaphorum.com)
Global medicines and the future outlook
In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to
Read more
2024-03-06 (liputan6.com)
Research: Adolescent Depression Increases, Use of Antidepressants Also Increases
Not a few young people admitted that they experienced poor mental health during and after the Covid-19 outbreak.
Read more
2024-02-22 (endpts.com)
Clinical trial starts slowed to below pre-pandemic levels last year, IQVIA analysis finds
Biopharma R&D spending rebounded in 2023, up $11 billion from 2022 following a steep post-pandemic decline. But the number of new clinical trial starts slowed to levels from before the Covid-19 pandemic, the data and services firm IQVIA said in a new report.
Read more
2024-01-26 (nutraingredients-usa.com)
PharmaLinea 2024 trends: From natural pain management to AI-powered ingredient discovery
There is a clear white space for pain management supplements in the market and significant opportunity to harness AI for innovation and discovery.
Read more
2024-01-15 (startupper.gr)
ATHINA: Implementation of an innovative European program to upgrade pandemic prevention begins
Everything about the Greek Startup Scene
Read more
2024-01-09 (laopiniondemalaga.es)
Masks and flu and covid tests are already in short supply in pharmacies: "No one wants to pay the price of bringing them from China"
Importers recognize that there is a shortage problem because the tests they had last year have expired and now it is expensive for them to bring them from the Asian country.
Read more